Euroapi S.A. (OTCMKTS:EAPIF) Stock Short Interest Report for October

Euroapi S.A. (OTCMKTS:EAPIF) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 28,026 shares, a growth of 63.3% from the September 30th total of 17,158 shares. Based on an average daily trading volume, of 549 shares, the short-interest ratio is presently 51.0 days.

Euroapi Price Performance

Shares of EAPIF remained flat at C$0.89 during mid-day trading on Monday. 14 shares of the stock were exchanged, compared to its average volume of 1,659. The firm has a 50-day moving average of C$0.99 and a two-hundred day moving average of C$1.53. Euroapi has a 12 month low of C$0.84 and a 12 month high of C$3.46.

Euroapi Company Profile

EUROAPI is a France-based pharmaceutical company that develops, manufactures and markets active pharmaceutical ingredients (APIs), the substances responsible for the therapeutic effects of medicines. The company supplies APIs for use in a range of prescription and over-the-counter medicines, serving pharmaceutical companies and other healthcare customers.

Its portfolio includes chemical and biological APIs, as well as specialized products such as peptides and complex molecules. EUROAPI also provides contract development and manufacturing services, supporting customers from process development and scale-up through commercial production and regulatory supply.

EUROAPI was established in 2022 through the separation and listing of Sanofi’s API business.